In NSCLC experimental models we have found that G9a/DNMT1 inhibition impairs cancer cell malignancy and reduces tumor growth, an effect that is mediated by enzymes AOX1 and SCARA5. This evidence concerns the gene DNMT1 and non-small cell lung carcinoma.